Sign In
Buy NDAQ
$82.49
-0.120 (-0.145%)
At Close: Jun 23, 2026
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Tuesday, 22'nd Apr 2025
NOVATO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for ra
Charles & Colvard, Ltd. Announces Delisting from Nasdaq
04:45pm, Tuesday, 22'nd Apr 2025
RESEARCH TRIANGLE PARK, N.C. , April 22, 2025 /PRNewswire/ -- Charles & Colvard, Ltd.
Marin Software Incorporated Receives Nasdaq Notification Regarding Late Form 10-K Filing and Continued Listing Requirements
04:15pm, Tuesday, 22'nd Apr 2025
SAN FRANCISCO--(BUSINESS WIRE)--Marin Software Incorporated (NASDAQ: MRIN) (“Marin,” “we,” “our,” or the “Company”), a provider of digital marketing software for performance-driven adv
Aptevo Therapeutics Announces the Closing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
04:05pm, Tuesday, 22'nd Apr 2025
SEATTLE, WA / ACCESS Newswire / April 22, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology
Nasdaq Gears Up to Report Q1 Earnings: Here's What to Expect
09:50am, Tuesday, 22'nd Apr 2025
NDAQ's Q1 results are likely to reflect new customer acquisitions, higher analytics revenues, eVestment product offerings, as well as growth in trading volume.
Femto Technologies Announces Reverse Split Implemented
08:05am, Tuesday, 22'nd Apr 2025
The reverse stock split is part of the Company's plan to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market April 22, 2025 – TheNewswire �
Nasdaq Dips Over 400 Points Amid Plunge In Tesla, Nvidia Shares: Greed Index Remains In 'Extreme Fear' Zone
02:40am, Tuesday, 22'nd Apr 2025
The CNN Money Fear and Greed index showed some easing in overall fear level, while the index remained in the “Extreme Fear” zone on Monday.
Cambium Networks receives deficiency notice from Nasdaq
04:30pm, Monday, 21'st Apr 2025
HOFFMAN ESTATES, Ill. , April 21, 2025 /PRNewswire/ -- Cambium Networks (NASDAQ: CMBM), a leading global provider of networking solutions, announced today that on April 16, 2025, it received an additi
Meiwu Technology Company Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
04:15pm, Monday, 21'st Apr 2025
Shenzhen, China, April 21, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited (“WNW” or the “Company”), (NASDAQ: WNW) announced today that it received a formal notification from the Nas
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Monday, 21'st Apr 2025
SAN DIEGO , April 21, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide
Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
02:40pm, Monday, 21'st Apr 2025
SEATTLE, WA / ACCESS Newswire / April 21, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology
Will Nasdaq (NDAQ) Beat Estimates Again in Its Next Earnings Report?
01:16pm, Monday, 21'st Apr 2025
Nasdaq (NDAQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
S&P 500 and Nasdaq Index: Trump Slams Powell as Tesla, Nvidia, and Amazon Lead Stock Selloff
12:04pm, Monday, 21'st Apr 2025
Trump's attack on Powell triggers a tech-led selloff; Tesla, Nvidia, and Amazon tumble as S&P 500 and Nasdaq drop sharply.
Nasdaq Tumbles Over 400 Points; Netflix Posts Upbeat Earnings
10:21am, Monday, 21'st Apr 2025
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 400 points on Monday.
Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
06:30am, Monday, 21'st Apr 2025
MANNHEIM, Germany, April 21, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, anno
